Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Stage

Acquired Unit | Acquired

Valuation

$0000 

Revenue

$0000 

About Fera Pharmaceuticals - Opthalmic Sterile Ointment and Solution Product Portfolio

Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in- licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets.In June 2013, Perrigo acquired the ophthalmic sterile ointment and solution product portfolio of Fera Pharmaceuticals for $93 million.

Fera Pharmaceuticals - Opthalmic Sterile Ointment and Solution Product Portfolio Headquarter Location

15R Birch Hill Road Suite A

Locust Valley, New York, 11560,

United States

414-434-6604

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.